 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, August 6, 2003, 23(18):7218-7226
Previous Article | Next Article
Group III Metabotropic Glutamate Receptor-Mediated Modulation of the Striatopallidal Synapse
Ornella Valenti, Michael J. Marino, Marion Wittmann, Edward Lis, Anthony G. DiLella, Gene G. Kinney, andP. Jeffrey Conn Department of Neuroscience, Merck Research Laboratories, West Point, Pennsylvania 19486
The globus pallidus (GP) is a key GABAergic nucleus in the basal ganglia (BG). The predominant input to the GP is an inhibitory striatal projection that forms the first synapse in the indirect pathway. The GP GABAergic neurons project to the subthalamic nucleus, providing an inhibitory control of these glutamatergic cells. Given its place within the BG circuit, it is not surprising that alterations in GP firing pattern are postulated to play a role in both normal and pathological motor behavior. Because the inhibitory striatal input to the GP may play an important role in shaping these firing patterns, we set out to determine the role that the group III metabotropic glutamate receptors (GluRs) play in modulating transmission at the striatopallidal synapse. In rat midbrain slices, electrical stimulation of the striatum evoked GABAA-mediated IPSCs recorded in all three types of GP neurons. The group III mGluR-selective agonist L-(+)-2-amino-4-phosphonobutyric acid (L-AP4) inhibited these IPSCs through a presynaptic mechanism of action. L-AP4 exhibited high potency and a pharmacological profile consistent with mediation by mGluR4. Furthermore, the effect of L-AP4 on striatopallidal transmission was absent in mGluR4 knock-out mice, providing convincing evidence that mGluR4 mediates this effect. The finding that mGluR4 may selectively modulate striatopallidal transmission raises the interesting possibility that activation of mGluR4 could decrease the excessive inhibition of the GP that has been postulated to occur in Parkinson's disease. Consistent with this, we find that intracerebroventricular injections of L-AP4 produce therapeutic benefit in both acute and chronic rodent models of Parkinson's disease.
Key words: basal ganglia; globus pallidus; metabotropic glutamate receptor; mGluR4; Parkinson's disease; synaptic transmission
Received Jan. 9, 2003; revised Jun. 16, 2003; accepted Jun. 23, 2003.
This article has been cited by other articles:
C. Beurrier, S. Lopez, D. Revy, C. Selvam, C. Goudet, M. Lherondel, P. Gubellini, L. Kerkerian-LeGoff, F. Acher, J.-P. Pin, et al.
Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism
FASEB J, October 1, 2009; 23(10): 3619 - 3628.
[Abstract] [Full Text] [PDF]
C. M. Niswender, K. A. Johnson, C. D. Weaver, C. K. Jones, Z. Xiang, Q. Luo, A. L. Rodriguez, J. E. Marlo, T. de Paulis, A. D. Thompson, et al.
Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4
Mol. Pharmacol., November 1, 2008; 74(5): 1345 - 1358.
[Abstract] [Full Text] [PDF]
S. Lopez, N. Turle-Lorenzo, F. Acher, E. De Leonibus, A. Mele, and M. Amalric
Targeting Group III Metabotropic Glutamate Receptors Produces Complex Behavioral Effects in Rodent Models of Parkinson's Disease
J. Neurosci., June 20, 2007; 27(25): 6701 - 6711.
[Abstract] [Full Text] [PDF]
Y. Lu
Endogenous mGluR Activity Suppresses GABAergic Transmission in Avian Cochlear Nucleus Magnocellularis Neurons
J Neurophysiol, February 1, 2007; 97(2): 1018 - 1029.
[Abstract] [Full Text] [PDF]
J. Feng
Microtubule: A Common Target for Parkin and Parkinson's Disease Toxins
Neuroscientist, December 1, 2006; 12(6): 469 - 476.
[Abstract] [PDF]
G. Battaglia, C. L. Busceti, G. Molinaro, F. Biagioni, A. Traficante, F. Nicoletti, and V. Bruno
Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
J. Neurosci., July 5, 2006; 26(27): 7222 - 7229.
[Abstract] [Full Text] [PDF]
Q. Jiang, Z. Yan, and J. Feng
Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism.
J. Neurosci., April 19, 2006; 26(16): 4318 - 4328.
[Abstract] [Full Text] [PDF]
M. Giustizieri, G. Bernardi, N. B. Mercuri, and N. Berretta
Distinct Mechanisms of Presynaptic Inhibition at GABAergic Synapses of the Rat Substantia Nigra Pars Compacta
J Neurophysiol, September 1, 2005; 94(3): 1992 - 2003.
[Abstract] [Full Text] [PDF]
J. P. Tyszkiewicz and Z. Yan
{beta}-Amyloid Peptides Impair PKC-Dependent Functions of Metabotropic Glutamate Receptors in Prefrontal Cortical Neurons
J Neurophysiol, June 1, 2005; 93(6): 3102 - 3111.
[Abstract] [Full Text] [PDF]
O. Valenti, G. Mannaioni, G. R. Seabrook, P. J. Conn, and M. J. Marino
Group III Metabotropic Glutamate-Receptor-Mediated Modulation of Excitatory Transmission in Rodent Substantia Nigra Pars Compacta Dopamine Neurons
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1296 - 1304.
[Abstract] [Full Text] [PDF]
C. Acuna-Goycolea, Y. Li, and A. N. van den Pol
Group III Metabotropic Glutamate Receptors Maintain Tonic Inhibition of Excitatory Synaptic Input to Hypocretin/Orexin Neurons
J. Neurosci., March 24, 2004; 24(12): 3013 - 3022.
[Abstract] [Full Text] [PDF]
M. J. Marino, D. L. Williams Jr., J. A. O'Brien, O. Valenti, T. P. McDonald, M. K. Clements, R. Wang, A. G. DiLella, J. F. Hess, G. G. Kinney, et al.
Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment
PNAS, November 11, 2003; 100(23): 13668 - 13673.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|